Skip to main content
. 2022 Aug 2;14(15):3767. doi: 10.3390/cancers14153767

Figure 2.

Figure 2

Diagram of current BPDCN management. The size of the circles represents the efficacy and frequency use of the treatment. The color of the circle represents the patient group the treatment is recommended to (fit (orange), unfit (gray), or after several failures (gold)). ALL, acute lymphoid leukemia; AML, acute myeloid leukemia; Allo-HSCT, allogenic hematopoietic stem cell transplantation; Auto-HSCT, autologous hematopoietic stem cell transplantation; BET, bromodomain and extraterminal domain; LXR, liver X receptor.